News Image

What's going on in today's after hours session

By Mill Chart

Last update: Nov 28, 2023

Curious about the stocks that are showing activity after the closing bell on Tuesday?

Gainers

TickerChangeComment
ATNF41.18%Positive market activity for 180 LIFE SCIENCES CORP (NASDAQ:ATNF) after regular trading hours, with a 41.18% increase to $0.48 in the after-hours session on Tuesday. Yesterday the company had a press release: 180 Life Sciences Announces Review of Strategic Alternatives.
RDHL11.4%REDHILL BIOPHARMA LTD-SP ADR's (NASDAQ:RDHL) shares rose 11.4% to $2.54 during Tuesday's after hours session. After a notable 128.0% gain earlier today, NASDAQ:RDHL maintains its positive momentum during the after-hours session.
GME9.71%GAMESTOP CORP-CLASS A's (NYSE:GME) shares rose 9.71% to $14.8. Today's after-hours session reflects the continued strength of NYSE:GME, following its 13.27% gain during the regular trading hours.
NTAP9.27%Promising after-hours performance observed for NETAPP INC (NASDAQ:NTAP) as its shares surged 9.27% to $85.35 during Tuesday's after-hours trading. yesterday the company released their earnings. Earlier today the company had a press release: NetApp and AWS Deliver a Nine Times Performance Increase for Amazon FSx for NetApp ONTAP.
ATXI9.07%AVENUE THERAPEUTICS INC (NASDAQ:ATXI) showcases remarkable after-hours performance, with a 9.07% rise to $0.2 during Tuesday's after-hours trading. Shareholders saw the stock price going 46.6% lower in the past month.
AULT7.14%AULT ALLIANCE INC's (NYSEARCA:AULT) shares rose 7.14% to $0.09 during Tuesday's after hours session. A press release (Ault Alliance Issues Letter to Stockholders Summarizing Third Quarter Financial Results and Updating on Capital Raising and Business Focus) was released two days ago.
IBIO5.0%Impressive after-hours gains for IBIO INC (NYSEARCA:IBIO) as its stock price advanced 5.0% to $0.21 during Tuesday's after-hours session. NYSEARCA:IBIO seems to be recovering from a -31.03% loss in the regular session.
SGMO4.62%After the regular session, SANGAMO THERAPEUTICS INC (NASDAQ:SGMO) continues to impress in the after-hours session, with a 4.62% increase to $0.41. In the last month the share price dropped with 25.65%.
ISUN4.49%ISUN INC (NASDAQ:ISUN) rose 4.49% to $0.21 during Tuesday's after hours session. The positive momentum from today's 17.03% gain carries over into the after-hours session, with 4.49% further growth.
WDAY4.28%Impressive after-hours gains for WORKDAY INC-CLASS A (NASDAQ:WDAY) as its stock price advanced 4.28% to $247.49 during Tuesday's after-hours session. The company's earnings where released Yesterday. In the last year the share price increased with 38.8%.

For the full after hours gainers list go to our after hours gainers page.

After hours losers

TickerChangeComment
SEEL-17.23%Price volatility persists as NASDAQ:SEEL closed the regular session with a 2.0K% loss, and the downward trend continues in the after-hours session. Price volatility intensifies as NASDAQ:SEEL retraces its 2.0K% gain during the after-hours session.
GCTK-15.51%GLUCOTRACK INC's (NASDAQ:GCTK) shares experienced a 15.51% decrease to $0.19 in the after-hours session. Shareholders saw the stock price going 21.62% higher in the past month.
LESL-14.95%LESLIE'S INC's (NASDAQ:LESL) stock price decreased by 14.95% to $4.95. LESLIE'S INC released earnings Yesterday. In the last 6 months the stock lost 43.27%.
NOGNW-11.48%SOFTWARE ACQ GROUP III -CW27's (NASDAQ:NOGNW) shares fell 11.48% to $0.01. The regular session ended on a negative note with NASDAQ:NOGNW closing -10.95% lower, and the after-hours session reflects a continuation of the bearish sentiment.
VERV-10.23%VERVE THERAPEUTICS INC's (NASDAQ:VERV) shares fell 10.23% to $10.71 during Tuesday's after hours session. A press release (Verve Therapeutics Announces Proposed Public Offering of Common Stock and Concurrent Private Placement) was released earlier today.
JBL-9.32%JABIL INC's (NYSE:JBL) stock price saw a decrease of 9.32% to $118.5 during Tuesday's after-hours session. Earlier today the company had a press release: Jabil Updates Fiscal 2024 Outlook.
CMND-7.23%CLEARMIND MEDICINE INC's (NASDAQ:CMND) shares experienced a 7.23% decrease to $3.08 in the after-hours session. Today's after-hours session indicates a reversal in NASDAQ:CMND's earlier 3.0K% gain, with prices exhibiting heightened volatility. A press release (Clearmind Medicine to Participate in Traditional vs. Novel Psychedelics Virtual Event with Leading Industry Figures) was released two days ago.
RMAX-6.9%RE/MAX HOLDINGS INC-CL A's (NYSE:RMAX) shares fell 6.9% to $8.5. In the last 3 months the stock lost 44.33%.
BCLI-6.27%BRAINSTORM CELL THERAPEUTICS's (NASDAQ:BCLI) stock price is showing a decline of 6.27% to a price of $0.21 during the after-hours session. Two days ago the company had a press release: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – BCLI.
BRSH-6.2%BRUUSH ORAL CARE INC's (NASDAQ:BRSH) shares experienced a 6.2% decrease to $0.18 in the after-hours session. Today's drop of -18.64% continued in today's after hours session with another decline of 6.2%

Our after hours losers page will show you the full list.

Back

SANGAMO THERAPEUTICS INC

NASDAQ:SGMO (2/22/2024, 7:09:37 PM)

After market: 1.11 +0.01 (+0.91%)

1.1

-0.13 (-10.93%)

SGMO News

News Image11 days ago - ChartmillThese stocks are moving in today's session

Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.

News Image11 days ago - Seeking AlphaSangamo stock soars 37% on updates for Fabry disease therapy (NASDAQ:SGMO)

Sangamo Therapeutics (SGMO) stock rallied 37% Monday after the biotech company announced regulatory updates for its gene therapy candidate ST-920 in the treatme

News Image11 days ago - ChartmillWhich stocks are gapping on Monday?

These stocks are gapping in today's session

News Image11 days ago - Sangamo Therapeutics, Inc.Sangamo Therapeutics Announces U.S. FDA Alignment on Abbreviated Pathway to Potential Approval and EMA Prime Eligibility for ST-920 in Fabry Disease
News Image18 days ago - Sangamo Therapeutics, Inc.Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit and Differentiated Safety Profile
News Image21 days ago - ChartmillWhich stocks are moving after the closing bell on Friday?

Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.

News Image21 days ago - Market News VideoCommit To Buy Sangamo Therapeutics At $0.50, Earn 55.9% Annualized Using Options
News Image3 months ago - BloombergA Biotech Slump Is Emptying Labs and Threatening Research on New Drugs

Sangamo Therapeutics Inc.’s cost cuts didn’t hurt just the roughly 162 US workers who lost their jobs this month. It’s also a blow to Jerry Walter, who’s lost five family members and suffered kidney, lung, hearing and heart damage from a rare disease.

News Image4 months ago - Seeking AlphaRBC Capital downgrades Sangamo as biotech moves to save cash (SGMO)

RBC Capital downgrades Sangamo Therapeutics (SGMO) due to workforce cuts and program pauses, lowering price target to $2 from $6. Read more here.

News Image4 months ago - Sangamo Therapeutics, Inc.Sangamo Therapeutics Announces Strategic Update and Reports Third Quarter 2023 Financial Results
SGMO Links
Follow us for more